A new trading day began on Tuesday, with Arcus Biosciences Inc (NYSE: RCUS) stock price down -7.89% from the previous day of trading, before settling in for the closing price of $9.12. RCUS’s price has ranged from $8.82 to $19.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 172.99% over the last five years. Meanwhile, its annual earnings per share averaged -31.67%. With a float of $64.90 million, this company’s outstanding shares have now reached $92.20 million.
The firm has a total of 627 workers. Let’s measure their productivity. In terms of profitability, gross margin is 98.06%, operating margin of -127.91%, and the pretax margin is -109.69%.
Arcus Biosciences Inc (RCUS) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Arcus Biosciences Inc is 38.68%, while institutional ownership is 49.40%. The most recent insider transaction that took place on Feb 27 ’25, was worth 201,200. In this transaction Director of this company bought 20,000 shares at a rate of $10.06, taking the stock ownership to the 28,400 shares. Before that another transaction happened on Feb 27 ’25, when Company’s Chief Executive Officer bought 19,800 for $10.18, making the entire transaction worth $201,465. This insider now owns 2,554,160 shares in total.
Arcus Biosciences Inc (RCUS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -31.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.81% during the next five years compared to -10.20% drop over the previous five years of trading.
Arcus Biosciences Inc (NYSE: RCUS) Trading Performance Indicators
Here are Arcus Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.10, a number that is poised to hit -1.02 in the next quarter and is forecasted to reach -4.19 in one year’s time.
Technical Analysis of Arcus Biosciences Inc (RCUS)
Analysing the last 5-days average volume posted by the [Arcus Biosciences Inc, RCUS], we can find that recorded value of 0.97 million was better than the volume posted last year of 0.96 million. As of the previous 9 days, the stock’s Stochastic %D was 13.81%. Additionally, its Average True Range was 0.60.
During the past 100 days, Arcus Biosciences Inc’s (RCUS) raw stochastic average was set at 0.84%, which indicates a significant decrease from 4.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.89% in the past 14 days, which was lower than the 60.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.47, while its 200-day Moving Average is $14.86. Now, the first resistance to watch is $8.92. This is followed by the second major resistance level at $9.45. The third major resistance level sits at $9.75. If the price goes on to break the first support level at $8.09, it is likely to go to the next support level at $7.79. Should the price break the second support level, the third support level stands at $7.26.
Arcus Biosciences Inc (NYSE: RCUS) Key Stats
With a market capitalization of 889.07 million, the company has a total of 105,138K Shares Outstanding. Currently, annual sales are 258,000 K while annual income is -283,000 K. The company’s previous quarter sales were 26,000 K while its latest quarter income was -94,000 K.
